Back
HCV Treatment 
HCV Drug Resistance
HCV Drug Resistance
IAS 2011: Boceprevir Response and Resistance Differs According to HCV Genotype 1 Subtype
- Details
- Category: HCV Drug Resistance
- Published on Tuesday, 26 July 2011 00:00
- Written by Liz Highleyman
People with hepatitis C virus (HCV) genotype 1b respond better to boceprevir and are less likely to develop drug resistance than those with genotype 1a, according to study findings reported last week at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Rome.
Web Design and Development by